If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
16.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (6.452%)
Market Cap: £13.20m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Portfolio News - Molendotech Collaboration

29 Jan 2018 07:00

RNS Number : 1274D
Frontier IP Group plc
29 January 2018
 

 

 

 

 

Frontier IP Group Plc

 

Portfolio News - Molendotech Collaboration with Palintest

 

 

Frontier IP, which specialises in the commercialisation of university intellectual property, is pleased to announce that portfolio company Molendotech Limited ("Molendotech"), a spin-out company from the University of Plymouth, has entered into a collaboration agreement with Palintest Limited ("Palintest"), a subsidiary of FTSE company Halma plc, for the development and licencing of water testing products.

 

Molendotech has developed a novel test which is able to identify the concentration of faecal bacteria in water. Molendotech's rapid, point-of-use test to determine water quality enables more informed decision-making about the use of water and significantly improves the ability to identify and track any pollution source. Molendotech now aims to bring its product to market and to develop further products for the water testing market, in collaboration with Palintest.

 

Professor Simon Jackson, Director of Molendotech, said, "We are delighted to announce our collaboration with Palintest, a market leader in water testing products. We are looking forward to working with Palintest to accelerate getting our products to market."

 

Simon Bowman, Technical Director of Palintest, said, "We are very excited to be working with the Molendotech team and pleased to bring our own know-how and expertise to develop and commercialise the Molendotech technology."

 

Neil Crabb, Chief Executive of Frontier IP, said, "Molendotech is showing strong potential and its technology is capable of addressing a wide range of water-testing applications from beaches to the beverage industry."

 

For further information:

 

Frontier IP Group Plc

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

T: 0131 240 1251

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Neil McDonald / Beth McKiernan

T: 0131 220 6939

Peterhouse Corporate Finance Limited (Joint Broker)

Lucy Williams

T: 020 7469 0935

Kreab (Financial PR)

Robert Speed / Matthew Jervois

T: 020 7074 1800

 

Notes to Editor:

 

About Frontier IP Group plc

 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

 

About Molendotech

 

Molendotech was created to develop and commercialise the work of Simon Jackson, Professor of Environment and Human Health within the Plymouth University, Peninsula Schools of Medicine and Dentistry. Molendotech develops a rapid assay to screen water for faecal contamination. Current tests on the market may take hours or even days to show results, whereas Molendotech's technology typically produces results in under 15 minutes. A patent has been filed in relation to the technology, which has already been granted in the US for recreational waters.

 

About Palintest

 

Palintest is a world-leading manufacturer of water testing kits and environmental products for water quality analysis in drinking water, Pools and Spas, waste water and effluent. Palintest is a wholly owned subsidiary of the FTSE 100 company Halma plc, which employs over 5,800 people in around 50 businesses, based in more than 20 countries, with major operations in Europe, USA and Asia.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEANFPAELPEFF
Date   Source Headline
6th Jul 20267:00 amRNS-RInSignals Neurotech Grant
30th Jun 20265:00 pmRNSTotal Voting Rights
26th Jun 202610:03 amRNSHolding(s) in Company
25th Jun 20262:44 pmRNSHolding(s) in Company
25th Jun 20267:00 amRNSHolding(s) in Company
24th Jun 20267:00 amRNS-RPortfolio news: Investment in Fieldwork Robotics
23rd Jun 20267:00 amRNSPosting of Circular and Notice of General Meeting
19th Jun 20267:00 amRNSResult of Retail Offer
17th Jun 20267:00 amRNSResult of Placing and Subscription
16th Jun 20265:20 pmRNSRetail Offer
16th Jun 20264:58 pmRNSProposed Placing and Subscription
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.